• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有 1 型脉络膜新生血管的中心性浆液性脉络膜视网膜病变的临床特征。

Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization.

机构信息

Department of Ophthalmology, Kagawa University Faculty of Medicine, Kagawa, Japan.

Department of Ophthalmology, Kagawa University Faculty of Medicine, Kagawa, Japan.

出版信息

Am J Ophthalmol. 2018 Sep;193:80-86. doi: 10.1016/j.ajo.2018.06.009. Epub 2018 Jun 27.

DOI:10.1016/j.ajo.2018.06.009
PMID:29940168
Abstract

PURPOSE

To evaluate the type 1 choroidal neovascularization (CNV) incidence and associated factors in eyes with central serous chorioretinopathy (CSC).

DESIGN

Retrospective case series.

METHODS

Records of 363 eyes (324 patients) with CSC were reviewed. Age, sex, CSC type, choroidal vascular hyperpermeability (CVH), best-corrected visual acuity (BCVA), subfoveal choroidal thickness (SCT), and systemic hypertension (HT) were assessed and compared between subjects with and without neovascular CSC.

RESULTS

We identified 219 and 144 eyes with chronic and acute CSC, respectively. The mean participant age was 55.2 ± 12.0 years, and 58 (15.6%) eyes had neovascular CSC. Age (no CNV: 54.8 ± 12.1 years, CNV: 57.3 ± 10.9 years; P = .118) and SCT (no CNV: 388.0 ± 104.5 μm, CNV: 377.4 ± 108.9 μm; P = .487) were comparable between eyes with and without CNV. However, BCVA (logarithm of the minimum angle of resolution) was significantly worse in subjects with CNV (0.28 ± 0.33 [20/38] vs 0.15 ± 0.29 [20/28]; P = .014). Neovascular CSC occurred more often in women (72 [23.6%] vs 20 [34.5%], P = .099) and in cases of chronic CSC (171 [56.1%] vs 48 [82.8%], P < .001), CVH (205 [67.2%] vs 58 [100%], P < .001), and HT (91 [29.8%] vs 24 [41.4%], P = .092). Chronic CSC (P = .001), female sex (P = .075), and poor BCVA (P = .091) were associated with neovascular CSC (multiple regression).

CONCLUSIONS

Chronic CSC, female sex, CVH, and poor BCVA are risk factors for CNV in eyes with CSC.

摘要

目的

评估中心性浆液性脉络膜视网膜病变(CSC)患者 1 型脉络膜新生血管(CNV)的发生率及相关因素。

设计

回顾性病例系列。

方法

对 363 只眼(324 例患者)的 CSC 记录进行了回顾。评估并比较了有和无新生血管性 CSC 的患者的年龄、性别、CSC 类型、脉络膜血管通透性增加(CVH)、最佳矫正视力(BCVA)、中心凹下脉络膜厚度(SCT)和高血压(HT)。

结果

我们分别确定了 219 只和 144 只慢性和急性 CSC 的眼。平均参与者年龄为 55.2±12.0 岁,58 只(15.6%)眼有新生血管性 CSC。年龄(无 CNV:54.8±12.1 岁,CNV:57.3±10.9 岁;P=0.118)和 SCT(无 CNV:388.0±104.5μm,CNV:377.4±108.9μm;P=0.487)在有和无 CNV 的眼中相似。然而,CNV 患者的 BCVA(最小分辨角对数)明显更差(0.28±0.33[20/38]与 0.15±0.29[20/28];P=0.014)。新生血管性 CSC 更常见于女性(72[23.6%]与 20[34.5%],P=0.099)和慢性 CSC(171[56.1%]与 48[82.8%],P<0.001)、CVH(205[67.2%]与 58[100%],P<0.001)和 HT(91[29.8%]与 24[41.4%],P=0.092)。慢性 CSC(P=0.001)、女性(P=0.075)和 BCVA 差(P=0.091)是 CSC 患者发生新生血管性 CSC 的相关因素(多元回归)。

结论

慢性 CSC、女性、CVH 和较差的 BCVA 是 CSC 患者发生 CNV 的危险因素。

相似文献

1
Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization.具有 1 型脉络膜新生血管的中心性浆液性脉络膜视网膜病变的临床特征。
Am J Ophthalmol. 2018 Sep;193:80-86. doi: 10.1016/j.ajo.2018.06.009. Epub 2018 Jun 27.
2
Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).经扫频源光学相干断层扫描血管造影(SS OCTA)诊断的新生血管性和非新生血管性慢性中心性浆液性脉络膜视网膜病变(CSC)的临床评估
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1581-1590. doi: 10.1007/s00417-019-04297-z. Epub 2019 Apr 29.
3
Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者脉络膜新生血管的 3 年随访。
Br J Ophthalmol. 2020 Nov;104(11):1561-1566. doi: 10.1136/bjophthalmol-2019-315302. Epub 2020 Feb 12.
4
Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.局限性脉络膜凹陷患者的临床和谱域光学相干断层扫描表现。
Ophthalmology. 2014 May;121(5):1029-35. doi: 10.1016/j.ophtha.2013.11.043. Epub 2014 Jan 16.
5
Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization.慢性中心性浆液性脉络膜视网膜病变和脉络膜新生血管中扁平不规则的视网膜色素上皮脱离
Am J Ophthalmol. 2015 May;159(5):890-903.e3. doi: 10.1016/j.ajo.2015.02.002. Epub 2015 Feb 20.
6
FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?中浆:平坦型不规则色素上皮脱离是一种厚脉络膜新生血管病变?
Retina. 2020 Sep;40(9):1724-1733. doi: 10.1097/IAE.0000000000002662.
7
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变的长期视力结果和致盲原因。
Ophthalmology. 2019 Apr;126(4):576-588. doi: 10.1016/j.ophtha.2018.12.048. Epub 2019 Jan 17.
8
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.通过增强深度成像和扫频源光学相干断层扫描测量中心性浆液性脉络膜视网膜病变的脉络膜厚度
BMC Ophthalmol. 2014 Nov 25;14:145. doi: 10.1186/1471-2415-14-145.
9
Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.点状高荧光斑作为中心性浆液性脉络膜视网膜病变和息肉状脉络膜血管病变的一种常见脉络膜病变。
Am J Ophthalmol. 2014 Dec;158(6):1155-1163.e1. doi: 10.1016/j.ajo.2014.08.010. Epub 2014 Aug 12.
10
Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.光学相干断层扫描评估中心性浆液性脉络膜视网膜病变的脉络膜视网膜厚度及造影改变。
Ophthalmology. 2012 Aug;119(8):1666-78. doi: 10.1016/j.ophtha.2012.02.021. Epub 2012 Apr 21.

引用本文的文献

1
Predictive factors for the development of macular neovascularization in chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变中黄斑新生血管形成的预测因素。
Sci Rep. 2025 Sep 1;15(1):32250. doi: 10.1038/s41598-025-17499-9.
2
Anatomical and Functional Outcomes of Anti-VEGF Therapy in Pachychoroid Neovasculopathy.抗血管内皮生长因子治疗厚脉络膜新生血管病的解剖学和功能学结果
Clin Ophthalmol. 2025 Aug 12;19:2699-2707. doi: 10.2147/OPTH.S529840. eCollection 2025.
3
Comparison of microvasculature between neovascular, non-neovascular chronic central serous chorioretinopathy cases and asymptomatic fellow eyes using swept-source optical coherence tomography angiography.
使用扫频光学相干断层扫描血管造影术比较新生血管性、非新生血管性慢性中心性浆液性脉络膜视网膜病变病例与无症状对侧眼之间的微血管系统。
Int Ophthalmol. 2025 Jul 18;45(1):297. doi: 10.1007/s10792-025-03673-5.
4
Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-Up.阿柏西普治疗慢性中心性浆液性脉络膜视网膜病变继发1型脉络膜新生血管的治疗与延长方案:三年随访
Clin Ophthalmol. 2025 Jul 8;19:2153-2163. doi: 10.2147/OPTH.S532424. eCollection 2025.
5
Treatment of central serous chorioretinopathy: new options for an old disease.中心性浆液性脉络膜视网膜病变的治疗:一种古老疾病的新选择
Eye (Lond). 2025 Jul 4. doi: 10.1038/s41433-025-03894-z.
6
Analysis of cytokine profiles in aqueous humor based on optical coherence tomography in pachychoroid spectrum diseases.基于光学相干断层扫描技术对厚脉络膜谱系疾病房水中细胞因子谱的分析
Sci Rep. 2025 Jul 1;15(1):20639. doi: 10.1038/s41598-025-04130-0.
7
Photodynamic treatment without verteporfin in chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变的无维替泊芬光动力治疗
BMC Ophthalmol. 2025 May 23;25(1):310. doi: 10.1186/s12886-025-04144-2.
8
Reduced choroidal vascular index and choroid structural changes extended beyond subfoveal area in chronic central serous chorioretinopathy eyes with macular neovascularization.在伴有黄斑新生血管的慢性中心性浆液性脉络膜视网膜病变眼中,脉络膜血管指数降低以及脉络膜结构改变超出了黄斑中心凹下区域。
Int J Ophthalmol. 2025 May 18;18(5):853-859. doi: 10.18240/ijo.2025.05.10. eCollection 2025.
9
Intravitreal conbercept for chronic central serous chorioretinopathy with occult CNV: a retrospective clinical study based on multimodal ophthalmic imaging.玻璃体内注射康柏西普治疗伴有隐匿性脉络膜新生血管的慢性中心性浆液性脉络膜视网膜病变:一项基于多模式眼科成像的回顾性临床研究
Front Med (Lausanne). 2025 Mar 25;12:1550543. doi: 10.3389/fmed.2025.1550543. eCollection 2025.
10
[Secondary choroidal neovascularization-Really so common?].[继发性脉络膜新生血管——真的如此常见吗?]
Ophthalmologie. 2025 Mar;122(3):196-200. doi: 10.1007/s00347-025-02197-8. Epub 2025 Feb 10.